78
- Malireddy K, Larson DW, Sandborn WJ, Loftus EV, Faubion WA, Pardi DS, et al. Recurrence
and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn
disease. Arch Surg. 2010;145(1):42–7. - Fazio VW, Marchetti F, Church M, Goldblum JR, Lavery C, Hull TL, et al. Effect of resection
margins on the recurrence of Crohn’s disease in the small bowel. A randomized controlled
trial. Ann Surg. 1996;224(4):563–71; discussion 71-3. - Doherty G, Bennett G, Patil S, Cheifetz A, Moss AC. Interventions for prevention of post-
operative recurrence of Crohn’s disease. Cochrane Database Syst Rev. 2009;4:Cd006873. - Ford AC, Khan KJ, Talley NJ, Moayyedi P. 5-aminosalicylates prevent relapse of Crohn’s
disease after surgically induced remission: systematic review and meta-analysis. Am
J Gastroenterol. 2011;106(3):413–20. - Peyrin-Biroulet L, Deltenre P, Ardizzone S, D’Haens G, Hanauer SB, Herfarth H, et al.
Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn’s
disease: a meta-analysis. Am J Gastroenterol. 2009;104(8):2089–96. - Arnott I, Mowat C, Ennis H, Keerie C, Lewis S, Kennedy N, Cahill A, Morris A, Dunlop M,
Bloom S, Lindsay J, Subramanian S, Satsangi J. The TOPPIC trial: a randomized, double-
blind parallel group trial of mercaptopurine vs placebo to prevent recurrence of Crohn’s dis-
ease following surgical resection in 240 patients. Gastroenterology. 2016;150(4):S182. - D’Haens GR, Vermeire S, Van Assche G, Noman M, Aerden I, Van Olmen G, et al. Therapy
of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a
controlled randomized trial. Gastroenterology. 2008;135(4):1123–9. - Singh S, Garg SK, Pardi DS, Wang Z, Murad MH, Loftus EV Jr. Comparative efficacy of phar-
macologic interventions in preventing relapse of Crohn’s disease after surgery: a systematic
review and network meta-analysis. Gastroenterology. 2015;148(1):64–76.e2; quiz e14. - Sorrentino D, Terrosu G, Avellini C, Beltrami CA, Bresadola V, Toso F. Prevention of
postoperative recurrence of Crohn’s disease by infliximab. Eur J Gastroenterol Hepatol.
2006;18(4):457–9. - Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, et al. Infliximab prevents
Crohn’s disease recurrence after ileal resection. Gastroenterology. 2009;136(2):441–50.e1;
quiz 716. - Regueiro M, Kip KE, Baidoo L, Swoger JM, Schraut W. Postoperative therapy with infliximab
prevents long-term Crohn’s disease recurrence. Clin Gastroenterol Hepatol. 2014;12(9):1494–
502.e1. - Sorrentino D, Paviotti A, Terrosu G, Avellini C, Geraci M, Zarifi D. Low-dose maintenance
therapy with infliximab prevents postsurgical recurrence of Crohn’s disease. Clin Gastroenterol
Hepatol. 2010;8(7):591–9.e1; quiz e78-9. - Yoshida K, Fukunaga K, Ikeuchi H, Kamikozuru K, Hida N, Ohda Y, et al. Scheduled inflix-
imab monotherapy to prevent recurrence of Crohn’s disease following ileocolic or ileal resec-
tion: a 3-year prospective randomized open trial. Inflamm Bowel Dis. 2012;18(9):1617–23. - Biancone L, Cretella M, Tosti C, Palmieri G, Petruzziello C, Geremia A, et al. Local injec-
tion of infliximab in the postoperative recurrence of Crohn’s disease. Gastrointest Endosc.
2006;63(3):486–92. - Armuzzi A, Felice C, Papa A, Marzo M, Pugliese D, Andrisani G, et al. Prevention of postop-
erative recurrence with azathioprine or infliximab in patients with Crohn’s disease: an open-
label pilot study. J Crohns Colitis. 2013;7(12):e623–9. - Savarino E, Dulbecco P, Bodini G, Assandri L, Savarino V. Prevention of postoperative
recurrence of Crohn’s disease by Adalimumab: a case series. Eur J Gastroenterol Hepatol.
2012;24(4):468–70. - Papamichael K, Archavlis E, Lariou C, Mantzaris GJ. Adalimumab for the prevention and/
or treatment of post-operative recurrence of Crohn’s disease: a prospective, two-year, single
center, pilot study. J Crohns Colitis. 2012;6(9):924–31. - Savarino E, Bodini G, Dulbecco P, Assandri L, Bruzzone L, Mazza F, et al. Adalimumab is
more effective than azathioprine and mesalamine at preventing postoperative recurrence of
Crohn’s disease: a randomized controlled trial. Am J Gastroenterol. 2013;108(11):1731–42.
B.H. Click and M. Regueiro